# FDA Inspection 1216239 - OneLegacy - August 23, 2023

Source: https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/ddc8e2e6-0fe7-486f-a529-c1a4be04fd99
Source feed: FDA_Inspections

> FDA Inspection 1216239 for OneLegacy on August 23, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216239
- Company Name: OneLegacy
- Inspection Date: 2023-08-23
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1060112 - 2018-06-27](https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/2942cb24-980f-4426-a4cf-1509285d5817)
- [FDA Inspection 981678 - 2016-02-16](https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/5bd69ac6-31e6-413f-82d6-fcec389aaf16)
- [FDA Inspection 836734 - 2013-05-08](https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/1a6c7af2-7431-4c26-a639-aa75fd172463)
- [FDA Inspection 736338 - 2011-07-21](https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/3e69326d-2a1f-498a-832e-8ead5fd3abbe)
- [FDA Inspection 590132 - 2009-05-27](https://www.globalkeysolutions.net/records/fda_inspections/onelegacy/f80ce644-e86a-483d-bca6-72511634b449)

Company: https://www.globalkeysolutions.net/companies/onelegacy/a8317694-235d-4011-8541-bc08f938877e

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d